Natural history of t(11;14) multiple myeloma-Reference-Cited by-同舟云学术

Natural history of t(11;14) multiple myeloma

Published:2017-06-27 Issue:1 Volume:32 Page:131-138
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lakshman A^ORCID,Alhaj Moustafa M,Rajkumar S V,Dispenzieri A,Gertz M A,Buadi F K,Lacy M Q,Dingli D,Fonder A L,Hayman S R,Hobbs M A,Gonsalves W I,Hwa Y L,Kapoor P,Leung N^ORCID,Go R S,Lin Y,Kourelis T V,Lust J A,Russell S J,Zeldenrust S R,Kyle R A,Kumar S K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017204.pdf

Reference31 articles.

1. Rajkumar SV . Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 2016; 91: 719–734.

2. Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp M-J, Harousseau J-L et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 2002; 99: 2185–2191.

3. Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ et al. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Blood 2002; 99: 3735–3741.

4. Segges P, Braggio E, Minnicelli C, Hassan R, Zalcberg IR, Maiolino A . Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context. Braz J Med Biol Res 2016; 49: e5034.

5. Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 2007; 109: 3489–3495.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine for multiple myeloma: The case for translocation (11;14);Cancer Treatment Reviews;2024-11

2. Biomarker-directed therapy in multiple myeloma;Current Opinion in Oncology;2024-08-23

3. Which factors are associated with adverse prognosis in multiple myeloma patients after surgery? - preliminary establishment and validation of the nomogram;World Journal of Surgical Oncology;2024-06-25

4. Prevalence of the t(11; 14)(q13; q32) immunoglobulin H/CCND1 in Mexican mestizos with multiple myeloma: A single institution experience;Iraqi Journal of Hematology;2024-01

5. The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma;Cancers;2023-12-13